← Eichor
Condition: Hepatic Decompensation Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Hepatic Decompensation

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Apixaban-PK Trial: Preventing Portal Hypertension Complications in Cirrhosis
Phase 4 · 1 location(s) · Asian Institute Of Medical Sciences · NCT07521332
Predictors of Decompensation, Acute-on-chronic Liver Failure and Mortality in Liver Cirrhosis
Phase N/A · 3 location(s) · Singapore General Hospital · NCT07438288
Non-selective Beta-blocker in Compensated Advanced Chronic Liver Disease
Phase 4 · 1 location(s) · Chinese University of Hong Kong · NCT06449339
hepatomiR cACLD Study
Phase N/A · 1 location(s) · Karl Landsteiner University of Health Sciences · NCT06432582
Carvedilol + Simvastatin vs. Carvedilol Alone for Cirrhosis and Cirrhotic Cardiomyopathy and Impact on Hepatic Decompens
NA · 1 location(s) · Post Graduate Institute of Medical Education and Research, C · NCT06431919
RTX001 Autologous Engineered Macrophages for Liver Cirrhosis
Phase 1/Phase 2 · 14 location(s) · Resolution Therapeutics Limited · NCT06823713
Validation of New Prognostic Biomarkers in Patients With Decompensated Cirrhosis
Phase N/A · 9 location(s) · European Foundation for Study of Chronic Liver Failure · NCT06855056
A Comparative Study of MRI and Ultrasound for Detection of Primary Hepatocellular Carcinoma, Body Composition and Risk F
Phase N/A · 1 location(s) · Mattias Ekstedt · NCT07291141
DICE Study- Diastolic Improvement With Carvedilol & Empagliflozin in Patients With Cirrhosis
Phase 4 · 1 location(s) · Post Graduate Institute of Medical Education and Research, C · NCT07322237
MONTEROSA - Italian Multicenter Observational Study to Evaluate Time to Clinical Hepatic Decompensation, Quality of Life
Phase N/A · 24 location(s) · AstraZeneca · NCT07607769
A PROspective Faecal MIcrobiota tranSplantation Trial to Improve outcomEs in Patients With Cirrhosis
Phase 3 · 23 location(s) · King's College London · NCT06461208
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.